1-4 of 4
R Greenwood
Close
Sort by
Journal Articles

Anti-Leukemic Activity of the TYK2 Selective Inhibitor Ndi-031301 in T-Cell Acute Lymphoblastic Leukemia

Koshi Akahane, MD PhD, Zhaodong Li, PhD, Julia Etchin, PhD, Alla Berezovskaya, Evisa Gjini, PhD, Craig E Masse, PhD, Wenyan Miao, PhD, Jennifer Rocnik, PhD, Rosana Kapeller, MD PhD, Jeremy R Greenwood, PhD, Hong Tiv, Takaomi Sanda, MD PhD, David M Weinstock, MD, A. Thomas Look, MD
Journal: Blood
Blood (2016) 128 (22): 1596.
https://doi.org/10.1182/blood.V128.22.1596.1596
Published: 2016
Journal Articles

Synergistic Blockade Of Activated B Cell-Like DLBCL Proliferation With a Selective Inhibitor Of IRAK4 In Combination With Inhibition Of The B-Cell Receptor Signaling Network

Divya Chaudhary, Nancy Wood, Donna L. Romero, Shaughnessy D. Robinson, Jeremy R Greenwood, Mee Shelley, Michael Morin, Rosana Kapeller, William F Westlin
Journal: Blood
Blood (2013) 122 (21): 3833.
https://doi.org/10.1182/blood.V122.21.3833.3833
Published: 2013
Journal Articles

Development of factor VIII:C antibodies in dogs with hemophilia A (factor VIII:C deficiency)

AR Giles, S Tinlin, H Hoogendoorn, P Greenwood, R Greenwood
Journal: Blood
Blood (1984) 63 (2): 451–456.
https://doi.org/10.1182/blood.V63.2.451.451
Published: 1984
Journal Articles

A canine model of hemophilic (factor VIII:C deficiency) bleeding

AR Giles, S Tinlin, R Greenwood
Journal: Blood
Blood (1982) 60 (3): 727–730.
https://doi.org/10.1182/blood.V60.3.727.727
Published: 1982